These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 36027671)

  • 1. Kratom use categories and their associations with co-occurring substance use and mental health disorder symptoms during the COVID-19 pandemic.
    Adzrago D; Obekpa EO; Suragh TA; John ER; Yeh PG; Gallardo KR; Wilkerson JM
    Drug Alcohol Depend; 2022 Oct; 239():109605. PubMed ID: 36027671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and description of kratom (Mitragyna speciosa) use in the United States: a cross-sectional study.
    Schimmel J; Amioka E; Rockhill K; Haynes CM; Black JC; Dart RC; Iwanicki JL
    Addiction; 2021 Jan; 116(1):176-181. PubMed ID: 32285981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-Report Data on Regular Consumption of Illicit Drugs and HIV Risk Behaviors after Kratom (
    Saref A; Suraya S; Singh D; Grundmann O; Narayanan S; Swogger MT; Prozialeck WC; Boyer E; Balasingam V
    J Psychoactive Drugs; 2020; 52(2):138-144. PubMed ID: 31682782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kratom Use Among U.S. Adolescents: Analyses of the 2019 National Survey on Drug Use and Health.
    Sharma V; Cottler LB; Bares CB; Lopez-Quintero C
    J Adolesc Health; 2022 Apr; 70(4):677-681. PubMed ID: 34836801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kratom use and mental health: A systematic review.
    Swogger MT; Walsh Z
    Drug Alcohol Depend; 2018 Feb; 183():134-140. PubMed ID: 29248691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polysubstance use profiles among US adults using Kratom (Mitragyna speciosa): A latent class analysis using The National Survey on Drug Use and Health (NSDUH).
    Falise AM; Hoeflich CC; Nutley SK; Lopez-Quintero C; Striley CW
    Am J Addict; 2023 Jan; 32(1):76-80. PubMed ID: 36222599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kratom (Mitragyna speciosa) dependence, withdrawal symptoms and craving in regular users.
    Singh D; Müller CP; Vicknasingam BK
    Drug Alcohol Depend; 2014 Jun; 139():132-7. PubMed ID: 24698080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabis and binge alcohol use among older individuals with major depressive episode.
    Choi NG; DiNitto DM; Marti CN; Choi BY
    Subst Abus; 2022; 43(1):657-665. PubMed ID: 34666638
    [No Abstract]   [Full Text] [Related]  

  • 9. Exploring the self-reported motivations of kratom (
    Grundmann O; Veltri CA; Morcos D; Knightes D; Smith KE; Singh D; Corazza O; Cinosi E; Martinotti G; Walsh Z; Swogger MT
    Am J Drug Alcohol Abuse; 2022 Jul; 48(4):433-444. PubMed ID: 35389321
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevalence of Kratom Use Disorder Among Kratom Consumers.
    Hill K; Grundmann O; Smith KE; Stanciu CN
    J Addict Med; 2024 May-Jun 01; 18(3):306-312. PubMed ID: 38441236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ecological Momentary Assessment of Self-Reported Kratom Use, Effects, and Motivations Among US Adults.
    Smith KE; Panlilio LV; Feldman JD; Grundmann O; Dunn KE; McCurdy CR; Garcia-Romeu A; Epstein DH
    JAMA Netw Open; 2024 Jan; 7(1):e2353401. PubMed ID: 38277146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Use of Benzodiazepines among Kratom (
    Singh D; Narayanan S; Grundmann O; Boyer EW; Vicknasingam B
    J Psychoactive Drugs; 2020; 52(1):86-92. PubMed ID: 31218929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and characteristics of self-reported kratom use in a representative US general population sample.
    Covvey JR; Vogel SM; Peckham AM; Evoy KE
    J Addict Dis; 2020; 38(4):506-513. PubMed ID: 32657217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Past-Year Kratom Use in the U.S.: Estimates From a Nationally Representative Sample.
    Palamar JJ
    Am J Prev Med; 2021 Aug; 61(2):240-245. PubMed ID: 34027890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association between E-cigarette use and Kratom use among US adults.
    Lee J; Terashima JP; Parker MA
    Prev Med; 2022 Nov; 164():107295. PubMed ID: 36208816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kratom: Implications for Health Care Providers.
    Goldin D; Salani D; Mckay M
    J Psychosoc Nurs Ment Health Serv; 2019 Dec; 57(12):15-20. PubMed ID: 31774129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Public Perceptions toward Kratom (
    Singh D; Narayanan S; Suraya S; Saref A; Grundmann O; Prozialeck WC; Corazza O; Swogger MT; Griffin O; Balasingam V
    J Psychoactive Drugs; 2020; 52(3):282-288. PubMed ID: 32153252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Social Functioning of Kratom (Mitragyna speciosa) Users in Malaysia.
    Singh D; Müller CP; Vicknasingam BK; Mansor SM
    J Psychoactive Drugs; 2015; 47(2):125-31. PubMed ID: 25950592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severity of Pain and Sleep Problems during Kratom (Mitragyna speciosa Korth.) Cessation among Regular Kratom Users.
    Singh D; Narayanan S; Vicknasingam BK; Prozialeck WC; Ramanathan S; Zainal H; Harun SN
    J Psychoactive Drugs; 2018; 50(3):266-274. PubMed ID: 29558272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations of Lifetime Nonmedical Opioid, Methamphetamine, and Kratom Use within a Nationally Representative US Sample.
    Smith KE; Rogers JM; Strickland JC
    J Psychoactive Drugs; 2022; 54(5):429-439. PubMed ID: 34842079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.